Study types
- article 11
- dataset 1
Condition tags
- endometriosis 10
- mesh:D004715 6
- dyspareunia 4
- mesh:D017699 3
- infertility 3
- mesh:D004412 2
- die_deep_infiltrating 1
- mesh:D004414 1
- dysmenorrhea 1
Top journals
Frequent coauthors
BACKGROUND: We aimed to quantify the time to diagnosis among women with endometriosis in the United States (US) and to identify patient- and physician-related factors affecting diagnostic delay. PATIENTS AND METHODS: An online cross-section…
INTRODUCTION: To examine the symptomatic burden of endometriosis on health-related quality of life (HRQL) in women in the United States (US). METHODS: A cross sectional web-based survey study was conducted among women using survey panels. T…
BACKGROUND/AIMS: To estimate the prevalence of diagnosed endometriosis (DE) in women in the United States and assess the associated symptomatic burden. METHODS: An online, cross-sectional survey of women aged 18-49 years was conducted from …
Background/Aims: To estimate the prevalence of diagnosed endometriosis (DE) in women in the United States and assess the associated symptomatic burden. Methods: An online, cross-sectional survey of women aged 18-49 years was conducted from …
Background/Aims: To estimate the prevalence of diagnosed endometriosis (DE) in women in the United States and assess the associated symptomatic burden. Methods: An online, cross-sectional survey of women aged 18-49 years was conducted from …
Endometriose betrifft weltweit 176 Mio. Frauen im gebährfähigen Alter. Die Beschwerden reichen von Dysmenorrhö, chronischen Beckenschmerzen bis hin zu Dyspareunie und Subfertilität. Eine retrospektive, longitudinale Fall-Kontroll-Studie hat…
OBJECTIVE: The aim of this study was to estimate the efficacy of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of endometriosis-associated pelvic pain. METHODS: This was a phase II, randomized, placeb…
OBJECTIVE: This descriptive study assessed the rate and costs of surgical procedures among newly diagnosed endometriosis patients. METHODS: Utilizing the Medstat MarketScan database, commercially insured women aged 18-45 with endometriosis …
OBJECTIVES: Persistence and compliance in women with endometriosis who are receiving gonadotropin-releasing hormone agonists (GnRH-a) may be limited by its hypoestrogenic side effects. Use of concomitant therapy with norethindrone acetate (…